Cutler Group LP Novo Nordisk A S Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Jan 18, 2024	BUY	$87.78 - $105.45 $263,340 - $316,350	3,000 New	3,000 $7,000
Q2 2022 Aug 04, 2022	SELL	$103.24 - $121.81 $20,648 - $24,362	-200 Reduced 66.67%	100 $0
Q1 2022 Apr 14, 2022	BUY	$93.1 - $112.54 $27,930 - $33,762	300 New	300 $2,000
Q2 2018 Aug 10, 2018	SELL	$44.29 - $50.42 $283,456 - $322,688	-6,400 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$48.49 - $58.14 $310,336 - $372,096	6,400 New	6,400 $3,000
Q4 2017 Jan 17, 2018	SELL	$47.53 - $53.73 $1.53 Million - $1.72 Million	-32,100 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$41.15 - $49.22 $1.32 Million - $1.58 Million	32,100	32,100 $156,000

1,954

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.